Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and Daewoong Pharmaceutical Co. Ltd., (KSX: 069620),
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and Daewoong Pharmaceutical Co. Ltd., (KSX: 069620),
AFC Energy (AIM: AFC), a leading provider of hydrogen power generation technologies, today confirms it has strengthened its commercial relationship with Industrie De Nora S.p.A with the signing of the next phase of the Joint Development Agreement, setting updated targets for mass manufacture in advance of commercial deployment.
Active Energy, the London quoted renewable energy business focussed on biomass, is pleased to announce that it has entered into a joint venture agreement (the “JV”), with Renewable Logistics Systems LLC (“RLS”), a supplier of saw-logs, pulpwood and wood chips to international and domestic markets.
ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, announces acquisition of IP and JV.
Chaarat (AIM:CGH), the AIM-quoted gold mining company with assets in the Kyrgyz Republic and Armenia, is pleased to announce that it has signed a binding term sheet to enter into a Joint Venture with Çiftay İnsaat Tahhüt ve Ticaret A.S., the Turkish mining and mine construction contractor, to collaborate on the Tulkubash and Kyzyltash projects in the Kyrgyz Republic.
SIMEC Atlantis Energy, a world leading developer of tidal energy projects, announces the formation of a joint venture company with Development Agency for Normandy (AD Normandy), the regional agency for economic development in Normandy and regional investment fund Normandie Participations, for the purpose of developing a large-scale project in Raz Blanchard, Normandie.